# US 2025/0154408 A1 · Quantum Dot, Method of Preparing the Quantum Dot, and Electronic Device and Composition Comprising the Quantum Dot

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2025/0154408 A1
- Document ID: US20250154408A1
- Status: Published application
- Kind: A1
- Application number: 18/940,016
- Filed: 2024-11-07
- Published: 2025-05-15
- Earliest claimed: 2023-11-10
- Assignees: Samsung Display Co., Ltd.
- Applicants: Samsung Display Co., Ltd.
- Inventors: Kawon PAK; Sungjae KIM; Youngsik KIM; Bitna YOON; Donghee LEE; Junehyuk JUNG
- Web page: https://patentgrep.com/patent/US20250154408A1

## CPC

- C09K 11/883: {with zinc or cadmium}
- C09K 11/025: {non-luminescent particle coatings or suspension media}
- C09K 11/0883: {Arsenides; Nitrides; Phosphides}
- C09K 11/623: {with zinc or cadmium}
- B82Y 20/00: Nanooptics, e.g. quantum optics or photonic crystals
- B82Y 40/00: Manufacture or treatment of nanostructures
- C09K: MATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
- B82Y: SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES

## Abstract

A quantum dot includes a nanoparticle and a heterofunctional ligand bonded to a surface of the nanoparticle and represented by Formula 1: M1(X1)(R1) [Formula 1] In Formula 1, M1 is a metal cation, X1 is a halide ion, and R1 is a hydrophilic group having 11 or more carbon atoms.

## Claims

### Claim 1

A quantum dot comprising:
a nanoparticle; and
a heterofunctional ligand bonded to a surface of the nanoparticle and represented by Formula 1:
M1(X1)(R1) [Formula 1]
wherein, in Formula 1,
M1 is a metal cation,
X1 is a halide ion, and
R1 is a hydrophilic group having 11 or more carbon atoms.

### Claim 2 (depends on 1)

The quantum dot of claim 1, wherein M1 is a cation of Zn, Cu, In, Ga, Cr, Mn, Fe, Co, Ni, Mg, Ca, Sc, Sn, Ti, V, Sr, Y, Zr, Nb, Mo, Cd, Ba, Au, Hg, Tl, or a combination thereof.

### Claim 3 (depends on 1)

The quantum dot of claim 1, wherein X1 is Cl− or Br−.

### Claim 4 (depends on 1)

The quantum dot of claim 1, wherein
R1 is a ligand represented by Formula 11:
*-L1-(R11)n1-T1 [Formula 11]
wherein, in Formula 11,
L1 is a linking group,
R11 is a hydrophilic unit,
n1 is an integer from 1 to 1,000,
T1 is a terminal group, and
* indicates a binding site to M1 in Formula 1.

### Claim 5 (depends on 4)

The quantum dot of claim 4, wherein in Formula 11,
L1 is a single bond, an ester group (—COO—), a carbonyl group (—CO—), an amide group (—C(═O)N—), an ether group (—O—), a sulfide group (—S—), a sulfoxide group (—SO—), a sulfonyl group (—SO2—), or a combination thereof.

### Claim 6 (depends on 4)

The quantum dot of claim 4, wherein in Formula 11,
R11 includes at least one of a repeating unit represented by Formula 11-1 and a repeating unit represented by Formula 11-2:
wherein, in Formulae 11-1 and 11-2,
R21 to R26 are each independently hydrogen, deuterium, —F, —Cl, —Br, —I, a hydroxy group, a substituted or unsubstituted C1-C60 alkyl group, a substituted or unsubstituted C2-C60 alkenyl group, a substituted or unsubstituted C2-C60 alkynyl group, a substituted or unsubstituted C1-C60 alkoxy group, a substituted or unsubstituted C3-C10 cycloalkyl group, a substituted or unsubstituted C1-C10 heterocycloalkyl group, a substituted or unsubstituted C3-C10 cycloalkenyl group, a substituted or unsubstituted C1-C10 heterocycloalkenyl group, a substituted or unsubstituted C6-C60 aryl group, a substituted or unsubstituted C6-C60 aryloxy group, a substituted or unsubstituted C6-C60 arylthio group, a substituted or unsubstituted C1-C60 heteroaryl group, a substituted or unsubstituted C1-C60 heteroaryloxy group, a substituted or unsubstituted C1-C60 heteroarylthio group, a substituted or unsubstituted monovalent non-aromatic condensed polycyclic group, or a substituted or unsubstituted monovalent non-aromatic heterocondensed polycyclic group.

### Claim 7 (depends on 4)

The quantum dot of claim 4, wherein in Formula 11,
T1 is hydrogen, deuterium, —OR31, —COOR31, —N(R31)(R32), —S(R31), or a C1-C20 alkyl group, and
R31 and R32 are each independently hydrogen, deuterium, or a C1-C20 alkyl group.

### Claim 8 (depends on 1)

The quantum dot of claim 1, wherein
the heterofunctional ligand represented by Formula 1 is represented by Formula 21:
wherein, in Formula 21,
T1 is hydrogen, deuterium, —OR31, —COOR31, —N(R31)(R32), —S(R31), or a C1-C20 alkyl group,
R31 and R32 are each independently hydrogen, deuterium, or a C1-C20 alkyl group, and
n1 is an integer from 5 to 1,000.

### Claim 9 (depends on 1)

The quantum dot of claim 1, wherein
the nanoparticle includes a core, and
the core includes a Group I-III-VI compound.

### Claim 10 (depends on 9)

The quantum dot of claim 9, wherein
the nanoparticle further includes a shell covering at least a portion of the core, and
the shell includes a Group II-VI compound, a Group III-V compound, a Group III-VI compound, a Group I-III-VI compound, a Group II-IV-V compound, a Group II-V compound, a Group IV-V compound, or a combination thereof.

### Claim 11 (depends on 10)

The quantum dot of claim 10, wherein
the core includes Cu, In, Ga, and Se, and
the shell includes ZnS.

### Claim 12 (depends on 1)

The quantum dot of claim 1, wherein the nanoparticle has a diameter in a range of about 0.5 nm to about 7 nm.

### Claim 13

A method of preparing a quantum dot, the method comprising adding a heterofunctional ligand represented by Formula 1 to a solution including a nanoparticle:
M1(X1)(R1) [Formula 1]
wherein, in Formula 1,
M1 is a metal cation,
X1 is a halide ion, and
R1 is a hydrophilic group having 11 or more carbon atoms.

### Claim 14 (depends on 13)

The method of claim 13, wherein in the adding of the heterofunctional ligand to the solution,
an organic ligand is bonded to the nanoparticle, and
the organic ligand and the heterofunctional ligand undergo ligand exchange.

### Claim 15 (depends on 13)

The method of claim 13, wherein in the adding of the heterofunctional ligand to the solution,
a content of the heterofunctional ligand is in a range of about 10 parts by weight to about 30 parts by weight, based on 100 parts by weight of the nanoparticle.

### Claim 16 (depends on 13)

The method of claim 13, further comprising:
purifying and powdering the solution by adding an organic solvent to the solution.

### Claim 17 (depends on 1)

A quantum dot composition comprising the quantum dot according to claim 1.

### Claim 18 (depends on 17)

The quantum dot composition of claim 17, further comprising:
a crosslinkable monomer and an initiator.

### Claim 19 (depends on 1)

An electronic device comprising the quantum dot of claim 1.

### Claim 20 (depends on 19)

The electronic device of claim 19, wherein
the electronic device comprises an optoelectronic device including the quantum dot, and
the optoelectronic device is a photovoltaic device, a photodiode, a phototransistor, a photomultiplier, a photo resistor, a photo detector, a light sensitive detector, a solid-state triode, a battery electrode, a light-emitting device, a light-emitting diode, an organic light-emitting device, a quantum dot light-emitting diode, a transistor, a solar cell, a laser, or a diode injection laser.
